Cigna Group unveils USD 3 billion plan: Cigna Group stock sits 2.61 percent below its high
Published on 10/26/2026 at 10:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSGrowth plan and market context
- The Cigna Group announced a USD 3 billion modernization initiative on September 30, 2026.
- The company targets 10-14 percent adjusted earnings per share growth through 2030.
- Cigna Group stock trades at EUR 274.65 at 10:51 a.m. CET at Lang & Schwarz on October 26, 2026, 0.24 percent below the Xetra close of October 23, 2026.
- Piper Sandler maintained an Overweight rating and a USD 370.00 target on October 23, 2026.
The Cigna Group (ISIN US1255231003) was trading at EUR 274.65 at Lang & Schwarz on October 26, 2026, at 10:51 a.m. CET, 0.24 percent below the Xetra close of October 23, 2026. On September 30, 2026, PR Newswire reported that Cigna had launched its Lead to One strategy and a USD 3 billion modernization and productivity initiative.
Three dated milestones
The latest strategic announcement followed a series of measurable operating updates. On July 30, 2026, Cigna reported quarterly adjusted earnings per share of USD 7.78 and revenue of USD 71.56 billion, according to MarketBeat. On October 2, 2026, Bernstein reissued an Outperform rating, while Piper Sandler raised its target to USD 370.00, as reported by Investing.com. The September 30 Investor Day then set the broader 2030 framework.
What does the plan change?
The modernization program gives Cigna a quantified cost and growth agenda. The September 30 release set 2026 adjusted revenue at USD 280 billion, adjusted earnings per share at least USD 30.45, and cumulative operating cash flow at USD 50 billion through 2030. It also targeted 10-14 percent annual adjusted earnings per share growth through 2030.
The operating mix is central to that ambition. Cigna expects Evernorth Health Services to deliver at least USD 6.90 billion in pre-tax adjusted income from operations in 2026, while Cigna Healthcare is targeted at USD 4.55 billion. The same release set Specialty and Care earnings growth at 8-12 percent through 2030, linking the modernization spending to a specific growth platform.
Dates and valuation
PR Newswire identifies November 5, 2026 as the date for Cigna's third-quarter 2026 results. The company is also listed with an October 29, 2026 reporting date by MetaCap. MarketBeat puts the average 12-month analyst target at USD 338.24 from 23 brokerages, with 15 buy ratings and eight holds.
Stock remains below yearly high
The euro quote sits 2.61 percent below its 52-week high of EUR 282.00 and 31.81 percent above its 52-week low of EUR 208.40, based on the October 26, 2026 quote. That valuation leaves the upcoming results as the next concrete test of whether the new investment program can support the stated earnings path.
The further course of trading is shown by the continuously updated real-time quote of Cigna Group stock.
Cigna Group stock facts
- Company: The Cigna Group
- ISIN: US1255231003
- Ticker: CI
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 26, 2026, 10:51 a.m. CET): EUR 274.65
- Change versus Xetra close: minus 0.24 percent
- Xetra close (October 23, 2026): EUR 275.30
- Market capitalization: USD 81.1 billion (as of October 25, 2026)
- 52-week range: EUR 208.40-EUR 282.00 (as of October 26, 2026)
Market context: Market report S&P 500.
